Mersana Therapeutics (0M4.F) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.18
-0.17
-0.16
-0.15

Details

Expected EPS
-0.15162501679
Actual EPS
-0.18185800000000002
Surprise EPS
-0.03
Surprise Percent
+19.94%

Description

Mersana Therapeutics (0M4.F) has reported earnings of -0.18185800000000002 per share for Q3 2024.

0 Comments

Share your thoughts